Page last updated: 2024-08-26

fulvestrant and Body Weight

fulvestrant has been researched along with Body Weight in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (23.08)18.2507
2000's9 (69.23)29.6817
2010's1 (7.69)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ignatiuk, VM; Izvolskaia, MS; Sharova, VS; Voronova, SN; Zakharova, LA1
Alfinito, PD; Atherton, J; Chen, X; Cosmi, S; Deecher, DC1
Badaue-Passos, D; Gomez-Sanchez, CE; Guo, F; Hay, M; Johnson, AK; Xue, B1
Hara, T; Noda, S; Sawaki, M; Takatsuki, M; Wada, T; Yamasaki, K1
Boujaoude, M; Missen, MA; Woodman, OL1
Diel, P; Fritzemeier, KH; Hertrampf, T; Laudenbach, U; Seibel, J1
Dipippo, VA; Powers, CA1
Flanagan, AM; Lea, CK1
Koos, RD; Pillai, SB; Rockwell, LC; Sherwood, OD1
Dobnig, H; Evans, GL; Turner, RT1
Altavilla, D; Calapai, G; Caputi, AP; Corrado, F; D'Anna, R; Deodato, B; Galeano, M; Marino, D; Minutoli, L; Saitta, A; Squadrito, F; Squadrito, G1
Carnes, K; Franca, LR; Hess, RA; Jackson, GL; Kuehl, DE; Nakai, M; Nie, R; Oliveira, CA; Zhou, Q1
Duckles, SP; Krause, DN; McNeill, AM; Stanczyk, FZ; Zhang, C1

Other Studies

13 other study(ies) available for fulvestrant and Body Weight

ArticleYear
Abolition of prenatal lipopolysaccharide-induced reproductive disorders in rat male offspring by fulvestrant.
    Andrologia, 2019, Volume: 51, Issue:3

    Topics: Animals; Body Weight; Estrogen Receptor Antagonists; Female; Fulvestrant; Infertility, Male; Lipopolysaccharides; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Sertoli Cells; Spermatids; Testis

2019
ICI 182,780 penetrates brain and hypothalamic tissue and has functional effects in the brain after systemic dosing.
    Endocrinology, 2008, Volume: 149, Issue:10

    Topics: Animals; Blood-Brain Barrier; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Ethinyl Estradiol; Female; Fulvestrant; Hot Flashes; Hypothalamus; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Ovariectomy; Rats; Rats, Sprague-Dawley; Skin Temperature; Uterus

2008
Sex differences and central protective effect of 17beta-estradiol in the development of aldosterone/NaCl-induced hypertension.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:5

    Topics: Administration, Oral; Aldosterone; Animals; Blood Pressure; Body Weight; Brain; Disease Models, Animal; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Ganglionic Blockers; Heart Rate; Hexamethonium; Hypertension; Infusion Pumps, Implantable; Male; Orchiectomy; Ovariectomy; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Sex Factors; Sodium Chloride; Sympathetic Nervous System; Time Factors

2009
Immature uterotrophic assay of estrogenic compounds in rats given diets of different phytoestrogen content and the ovarian changes with ICI 182,780 or antide.
    Archives of toxicology, 2002, Volume: 76, Issue:11

    Topics: Animals; Benzhydryl Compounds; Body Weight; Dose-Response Relationship, Drug; Estradiol; Estrogens, Non-Steroidal; Ethinyl Estradiol; Female; Fulvestrant; Genistein; Isoflavones; Oligopeptides; Organ Size; Ovary; Phenols; Phytoestrogens; Plant Preparations; Rats; Rats, Sprague-Dawley; Uterus

2002
Daidzein and 17 beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1.
    Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:2

    Topics: Acetylcholine; Animals; Aorta; Body Weight; Calmodulin; Caveolin 1; Caveolins; Cyclic GMP; Drug Synergism; Endothelium, Vascular; Estradiol; Fulvestrant; Gene Expression; Injections, Subcutaneous; Isoflavones; Isoproterenol; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Nitroprusside; Organ Size; Phenoxybenzamine; Rats; Rats, Sprague-Dawley; Testis

2004
Analysis of the effects of oestrogen receptor alpha (ERalpha)- and ERbeta-selective ligands given in combination to ovariectomized rats.
    British journal of pharmacology, 2008, Volume: 153, Issue:7

    Topics: Animals; Body Weight; Bone Density; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Fulvestrant; Genistein; Ligands; Motor Activity; Ovariectomy; Phytoestrogens; Rats; Rats, Wistar

2008
Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 281, Issue:1

    Topics: Animals; Body Weight; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Malate Dehydrogenase; Organ Size; Ovariectomy; Rats; Receptors, Estrogen; Receptors, Thyroid Hormone; Tamoxifen; Thyroidectomy; Triglycerides; Triiodothyronine; Uterus

1997
Ovarian androgens protect against bone loss in rats made oestrogen deficient by treatment with ICI 182,780.
    The Journal of endocrinology, 1999, Volume: 160, Issue:1

    Topics: Analysis of Variance; Androgen Antagonists; Anilides; Animals; Aromatase; Body Weight; Bone and Bones; Bone Remodeling; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Interleukin-6; Nitriles; Organ Size; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tosyl Compounds; Uterus

1999
Relaxin stimulates uterine edema via activation of estrogen receptors: blockade of its effects using ICI 182,780, a specific estrogen receptor antagonist.
    Endocrinology, 1999, Volume: 140, Issue:5

    Topics: Animals; Body Weight; Edema; Endometrium; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Organ Size; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Relaxin; Uterine Diseases; Uterus

1999
The high-affinity estrogen receptor antagonist ICI 182,780 has no effect on bone growth in young male rats.
    Calcified tissue international, 2000, Volume: 66, Issue:6

    Topics: Animals; Body Weight; Estradiol; Estrogen Antagonists; Fulvestrant; Male; Orchiectomy; Osteogenesis; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tibia

2000
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats.
    Laboratory investigation; a journal of technical methods and pathology, 2001, Volume: 81, Issue:2

    Topics: Acetylcholine; Animals; Aorta; Blood Pressure; Body Weight; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Female; Fulvestrant; Heart Rate; In Vitro Techniques; Isoflavones; Lung; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; Organ Size; Ovariectomy; Phytoestrogens; Plant Preparations; Rats; Rats, Sprague-Dawley; Reference Values; Uterus; Zeranol

2001
ER function in the adult male rat: short- and long-term effects of the antiestrogen ICI 182,780 on the testis and efferent ductules, without changes in testosterone.
    Endocrinology, 2002, Volume: 143, Issue:6

    Topics: Acid Phosphatase; Animals; Atrophy; Blotting, Northern; Body Weight; Ejaculatory Ducts; Estradiol; Estrogen Antagonists; Fulvestrant; Gene Expression Regulation, Enzymologic; Immunohistochemistry; Male; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Seminiferous Tubules; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Testis; Testosterone

2002
Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone.
    Stroke, 2002, Volume: 33, Issue:6

    Topics: Animals; Blood Vessels; Body Weight; Brain; Dose-Response Relationship, Drug; Drug Implants; Enzyme Activation; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fulvestrant; In Vitro Techniques; Medroxyprogesterone Acetate; Models, Animal; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organ Size; Ovariectomy; Progesterone; Rats; Rats, Inbred F344; Receptors, Estrogen; Tamoxifen; Uterus

2002